Categories LATEST
Gilead Sciences Q3 2023 Earnings: Stay tuned for the live earnings call and real-time transcript
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, will be reporting third-quarter results today at 4:00 p.m. ET.
Listen to Gilead Sciences‘ earnings call live and check the real-time transcript
Analysts’ consensus estimate for September-quarter earnings is $1.81 per share, on an adjusted basis, which marks a decline from $1.90 per share the company earned in the year-ago quarter. Revenue is expected to be $6.42 billion, up 4.8% year-over-year.
For the second quarter, the company reported total revenue of $6.6 billion, which is up 5% year-over-year. Net income attributable to Gilead was $1 billion or $0.83 per share in Q2, compared to $1.1 billion, or $0.91 per share last year. Adjusted EPS decreased 15% to $1.34.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
